NSE BSE
indrayani biotech ltd. stock

INDRAYANI BIOTECH LTD. Share Price

- - (%)
- NSE: INDRANIB

INDRAYANI BIOTECH LTD. Share Price Update

As of the latest trading session, INDRAYANI BIOTECH LTD. share price is currently at 52.73, which is up by 1.02 from its previous closing. Today, the stock has fluctuated between 52.72 and 52.73. Over the past year, INDRAYANI BIOTECH LTD. has achieved a return of -12.36 %. In the last month alone, the return has been -8.51 %. Read More...

INDRAYANI BIOTECH LTD. Performance

Day Range

Low52.72 High52.73
53.17

52 Week Range

Low 44.40 High 99.70
53.17

INDRAYANI BIOTECH LTD. Share Price

526445

INDRANIB

img img img img
No Data Available

Open Price

52.72

Prev. Close

51.70

Volume (Shares)

9957.00

Total traded value

5.32

Upper Circuit

.00

Lower Circuit

.00

Note: The current prices & values are delayed, Login to your account for live updates.

INDRAYANI BIOTECH LTD. Fundamentals


(Standalone)

Market Cap (Cr) 180.48
PE Ratio (TTM) 166.16
Book Value / Share 11.97
Beta 0.55
ROE 12.48%
EPS (TTM) 0.32
Dividend Yield 0.00%
Net Profit Qtr (Cr) 0.07

INDRAYANI BIOTECH LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars MAR 2024 (Values in Cr)
Revenue 15.80
Operating Expense 17.62
Net Profit 0.07
Net Profit Margin (%) 0.44
Earnings Per Share (EPS) 0.08
EBITDA 4.43
Effective Tax Rate (%) 95.67
Particulars DEC 2023 (Values in Cr)
Revenue 13.69
Operating Expense 13.51
Net Profit 0.26
Net Profit Margin (%) 1.89
Earnings Per Share (EPS) 0.06
EBITDA 1.41
Effective Tax Rate (%) 0.00
Particulars SEP 2023 (Values in Cr)
Revenue 16.01
Operating Expense 15.70
Net Profit 0.41
Net Profit Margin (%) 2.56
Earnings Per Share (EPS) 0.12
EBITDA 1.40
Effective Tax Rate (%) 0.00
Particulars JUN 2023 (Values in Cr)
Revenue 16.82
Operating Expense 16.11
Net Profit 0.72
Net Profit Margin (%) 4.28
Earnings Per Share (EPS) 0.21
EBITDA 2.04
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Revenue 21.30
Operating Expense 20.58
Net Profit 0.87
Net Profit Margin (%) 4.08
Earnings Per Share (EPS) 0.25
EBITDA 2.59
Effective Tax Rate (%) 0.00
Particulars MAR 2024 (Values in Cr)
Revenue 62.32
Operating Expense 62.94
Net Profit 1.46
Net Profit Margin (%) 2.34
Earnings Per Share (EPS) 0.32
EBITDA 9.29
Effective Tax Rate (%) 51.49
Particulars MAR 2023 (Values in Cr)
Revenue 74.48
Operating Expense 69.54
Net Profit 5.06
Net Profit Margin (%) 6.79
Earnings Per Share (EPS) 1.48
EBITDA 8.79
Effective Tax Rate (%) 0.39
Particulars MAR 2022 (Values in Cr)
Revenue 57.99
Operating Expense 53.98
Net Profit 4.23
Net Profit Margin (%) 7.29
Earnings Per Share (EPS) 1.23
EBITDA 6.45
Effective Tax Rate (%) 0.00
Particulars MAR 2021 (Values in Cr)
Revenue 21.01
Operating Expense 28.05
Net Profit -10.89
Net Profit Margin (%) -51.83
Earnings Per Share (EPS) -3.18
EBITDA -8.53
Effective Tax Rate (%) 0.00
Particulars MAR 2020 (Values in Cr)
Revenue 49.90
Operating Expense 49.29
Net Profit 0.81
Net Profit Margin (%) 1.62
Earnings Per Share (EPS) 0.24
EBITDA 2.96
Effective Tax Rate (%) 0.00
Particulars MAR 2023 (Values in Cr)
Book Value / Share 12.94
ROE % 29.31
ROCE % 19.98
Total Debt to Total Equity 1.12
EBITDA Margin 13.07
Particulars MAR 2022 (Values in Cr)
Book Value / Share 7.06
ROE % 16.46
ROCE % 14.34
Total Debt to Total Equity 0.78
EBITDA Margin 11.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.76
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.58
EBITDA Margin -22.19
Particulars MAR 2020 (Values in Cr)
Book Value / Share 0.70
ROE % 2.37
ROCE % 4.09
Total Debt to Total Equity 0.45
EBITDA Margin 5.95
Particulars MAR 2012 (Values in Cr)
Book Value / Share 9.51
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 1.22
Particulars MAR 2023 (Values in Cr)
Book Value / Share 11.79
ROE % 12.48
ROCE % 10.48
Total Debt to Total Equity 0.81
EBITDA Margin 11.90
Particulars MAR 2022 (Values in Cr)
Book Value / Share 7.06
ROE % 15.61
ROCE % 14.18
Total Debt to Total Equity 0.73
EBITDA Margin 11.14
Particulars MAR 2021 (Values in Cr)
Book Value / Share 5.83
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.57
EBITDA Margin -20.94
Particulars MAR 2020 (Values in Cr)
Book Value / Share 0.70
ROE % 4.83
ROCE % 8.18
Total Debt to Total Equity 0.48
EBITDA Margin 5.95
Particulars MAR 2019 (Values in Cr)
Book Value / Share -1.80
ROE % 0.00
ROCE % 0.00
Total Debt to Total Equity 0.00
EBITDA Margin 0.00
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 3.03
Total Assets 155.96
Total Liabilities 155.96
Total Equity 48.35
Share Outstanding 34227192
Price to Book Ratio 4.79
Return on Assets (%) 7.64
Return on Capital (%) 10.74
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.50
Total Assets 51.40
Total Liabilities 51.40
Total Equity 24.56
Share Outstanding 34227192
Price to Book Ratio 4.32
Return on Assets (%) 8.63
Return on Capital (%) 10.46
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.67
Total Assets 40.05
Total Liabilities 40.05
Total Equity 20.08
Share Outstanding 34227192
Price to Book Ratio 1.09
Return on Assets (%) -27.99
Return on Capital (%) -31.49
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 51.47
Total Liabilities 51.47
Total Equity 30.83
Share Outstanding 3643860
Price to Book Ratio 11.93
Return on Assets (%) 1.56
Return on Capital (%) 1.81
Particulars MAR 2012 (Values in Cr)
Cash & Short Term Investments 1.19
Total Assets 12.29
Total Liabilities 12.29
Total Equity 3.51
Share Outstanding 3643860
Price to Book Ratio 0.00
Return on Assets (%) -0.52
Return on Capital (%) -1.21
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 0.61
Total Assets 100.29
Total Liabilities 100.29
Total Equity 51.14
Share Outstanding 34227192
Price to Book Ratio 4.79
Return on Assets (%) 5.04
Return on Capital (%) 5.85
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.44
Total Assets 49.43
Total Liabilities 49.43
Total Equity 24.17
Share Outstanding 34227192
Price to Book Ratio 4.32
Return on Assets (%) 8.54
Return on Capital (%) 10.33
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.62
Total Assets 39.84
Total Liabilities 39.84
Total Equity 19.95
Share Outstanding 34227192
Price to Book Ratio 1.09
Return on Assets (%) -27.32
Return on Capital (%) -30.77
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.40
Total Assets 51.47
Total Liabilities 51.47
Total Equity 30.83
Share Outstanding 3643860
Price to Book Ratio 11.93
Return on Assets (%) 1.56
Return on Capital (%) 1.81
Particulars MAR 2019 (Values in Cr)
Cash & Short Term Investments 0.00
Total Assets 0.00
Total Liabilities 0.00
Total Equity -0.65
Share Outstanding 3643860
Price to Book Ratio -3.89
Return on Assets (%) -959.42
Return on Capital (%) 403.98
Particulars MAR 2023 (Values in Cr)
Net Income 11.93
Cash from Operations 16.18
Cash from Investing -47.39
Cash from Financing 32.73
Net change in Cash 1.53
Free Cash Flow 40.08
Particulars MAR 2022 (Values in Cr)
Net Income 4.43
Cash from Operations 4.11
Cash from Investing -0.55
Cash from Financing -2.72
Net change in Cash 0.82
Free Cash Flow 5.30
Particulars MAR 2021 (Values in Cr)
Net Income -11.21
Cash from Operations 0.25
Cash from Investing -0.70
Cash from Financing -0.27
Net change in Cash -0.72
Free Cash Flow 0.95
Particulars MAR 2020 (Values in Cr)
Net Income 0.80
Cash from Operations 5.95
Cash from Investing -3.66
Cash from Financing -1.28
Net change in Cash 1.01
Free Cash Flow 9.44
Particulars MAR 2023 (Values in Cr)
Net Income 5.05
Cash from Operations 8.33
Cash from Investing -14.09
Cash from Financing 4.93
Net change in Cash -0.82
Free Cash Flow 10.23
Particulars MAR 2022 (Values in Cr)
Net Income 4.22
Cash from Operations 3.46
Cash from Investing 0.58
Cash from Financing -3.23
Net change in Cash 0.81
Free Cash Flow 3.52
Particulars MAR 2021 (Values in Cr)
Net Income -10.88
Cash from Operations 0.51
Cash from Investing -0.56
Cash from Financing -0.73
Net change in Cash -0.77
Free Cash Flow 0.90
Particulars MAR 2020 (Values in Cr)
Net Income 0.80
Cash from Operations 5.95
Cash from Investing -3.66
Cash from Financing -1.28
Net change in Cash 1.01
Free Cash Flow 9.44
Particulars MAR 2019 (Values in Cr)
Net Income -0.05
Cash from Operations -0.20
Cash from Investing 0.00
Cash from Financing 0.20
Net change in Cash 0.00
Free Cash Flow -0.20
Company Name Price P/E P/B Market Cap 52 Week Low/High
INDRAYANI BIOTECH LTD. 53.17 37.98 3.60 242.12 44.40 / 99.70
ASIAN HOTELS (NORTH) LTD 170.00 0.00 -1.38 330.65 108.25 / 241.20
EIH LIMITED 398.10 38.61 6.31 24895.75 205.05 / 566.00
GRAVISS HOSPITALITY LTD. 49.90 116.05 1.92 351.89 23.72 / 66.29
THE INDIAN HOTELS CO. LTD 577.25 66.12 8.68 82167.63 371.45 / 663.40
Company Name Price P/E P/B Market Cap 52 Week Low/High
INDRAYANI BIOTECH LTD. 53.17 166.16 4.44 242.12 44.40 / 99.70
ARUNA HOTELS LTD. 9.88 0.00 0.25 33.49 9.47 / 23.38
ASIAN HOTELS (NORTH) LTD 170.00 0.00 -1.00 330.65 108.25 / 241.20
EIH LIMITED 398.10 42.85 6.97 24895.75 205.05 / 566.00
GRAVISS HOSPITALITY LTD. 49.90 84.58 1.75 351.89 23.72 / 66.29

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 53.40
  • 26 Days 54.80
  • 10 Days 54.30
  • 50 Days 54.40
  • 12 Days 54.90
  • 100 Days 57.60
  • 20 Days 56.30
  • 200 Days 53.70
53.90
PIVOT
First Resistance 54.60
Second Resistance 54.96
Third Resistance 55.66
First Support 53.54
Second Support 52.84
Third Support 52.48
RSI 18.24
MACD 0.13
Commodity Channel Index (CCI) -79.50
ADX 29.85
Williams % R -88.01

Over 1 Month

down

-8.51

Over 3 Months

down

-6.70

Over 6 Months

down

-40.52

Over 1 Year

down

-12.36

Over 3 Years

down

76.50

Over 5 Years

down

57.99

INDRAYANI BIOTECH LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

INDRAYANI BIOTECH LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
66.51
Promoter Holdings
33.48
FII
0.0
DII
0.0
Promoter Shares(Pledge Percentage)
15.02
Name Category Shares Shares%
Jayaseelan Singaravelu Public Shareholding 4615796.0 10.14
G Swaminathan . Shareholding of Promoter and Promoter Group 4140000.0 9.09
Sayee Sundar Kasiraman Shareholding of Promoter and Promoter Group 2631569.0 5.78
S Indirakumar . Shareholding of Promoter and Promoter Group 2098600.0 4.61
I Umasundari . Shareholding of Promoter and Promoter Group 2098600.0 4.61
Next Orbit Ventures Fund Public Shareholding 1852485.0 4.07
Ajitkumar C Patel Public Shareholding 1300000.0 2.85
Rajasthan Global Securities Private Limited Public Shareholding 1241154.0 2.73
R Raja . Public Shareholding 1080000.0 2.37
Malarvannan Subashini Public Shareholding 1059064.0 2.33
M Ramesh . Shareholding of Promoter and Promoter Group 1050000.0 2.31
Jothi Ramesh . Shareholding of Promoter and Promoter Group 1050000.0 2.31
Sridhar Muthuraman Public Shareholding 1000000.0 2.2
Thirumeni Thiruselvaraja . Shareholding of Promoter and Promoter Group 822889.0 1.81
S Prakash Public Shareholding 777500.0 1.71
S I Dinesh Kumar . Shareholding of Promoter and Promoter Group 700000.0 1.54
V Agathiyan . Shareholding of Promoter and Promoter Group 651500.0 1.43
Geetha Kannan Public Shareholding 500000.0 1.1
Ramya M . Shareholding of Promoter and Promoter Group 1400.0 0.0
K Logan . Shareholding of Promoter and Promoter Group 1400.0 0.0

INDRAYANI BIOTECH LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date

Learn More About Stocks

About INDRAYANI BIOTECH LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by INDRAYANI BIOTECH LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 5x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Indrayani Biotech Ltd?

Answer Field

The share price of Indrayani Biotech Ltd for NSE is ₹ 0.00 and for BSE is ₹ 53.17.

What is the Market Cap of Indrayani Biotech Ltd?

Answer Field

The market cap of Indrayani Biotech Ltd for NSE is ₹ 0.0 Cr. and for BSE is ₹ 2,42.10 Cr. as of now.

What is the 52 Week High and Low of Indrayani Biotech Ltd?

Answer Field

The 52 Week High and Low of Indrayani Biotech Ltd for NSE is ₹ 0.00 and ₹ 0.00 and for BSE is ₹ 99.70 and ₹ 44.40.

How to Buy Indrayani Biotech Ltd share?

Answer Field

You can trade in Indrayani Biotech Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Indrayani Biotech Ltd?

Answer Field

The 1 year returns on the stock has been -12.36%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs+ Users

icon-with-text

4.3+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4300 Cr MTF Book

icon-with-text
loader